The Oncology Podcast

Unpacking Endometrial Cancer with Professor Linda Mileshkin

February 02, 2024 The Oncology Network Season 1 Episode 27
Unpacking Endometrial Cancer with Professor Linda Mileshkin
The Oncology Podcast
More Info
The Oncology Podcast
Unpacking Endometrial Cancer with Professor Linda Mileshkin
Feb 02, 2024 Season 1 Episode 27
The Oncology Network

Welcome to Episode 27 of The Oncology Podcast's Experts On Point series, brought to you by The Oncology Network. 

Endometrial cancer is the most common gynaecological cancer in Australia and advanced disease and early on set disease is increasing.

In today’s episode, our Host Rachael Babin is joined by Professor Linda Mileshkin Director of Medical oncology at the Peter MacCallum Cancer Centre in Melbourne, Australia.

They discuss new treatment options, clinical trials and collaborative research efforts such as the EDEN initiative. 

They also discuss stigma, shame and society’s silence around gynaecological cancers.

We hope you enjoy listening.

For news and podcast updates subscribe to The Oncology Newsletter,  a free weekly publication for healthcare professionals with an interest in oncology. Click here to subscribe.

PART OF THE ONCOLOGY NETWORK... Join Us

Show Notes

Welcome to Episode 27 of The Oncology Podcast's Experts On Point series, brought to you by The Oncology Network. 

Endometrial cancer is the most common gynaecological cancer in Australia and advanced disease and early on set disease is increasing.

In today’s episode, our Host Rachael Babin is joined by Professor Linda Mileshkin Director of Medical oncology at the Peter MacCallum Cancer Centre in Melbourne, Australia.

They discuss new treatment options, clinical trials and collaborative research efforts such as the EDEN initiative. 

They also discuss stigma, shame and society’s silence around gynaecological cancers.

We hope you enjoy listening.

For news and podcast updates subscribe to The Oncology Newsletter,  a free weekly publication for healthcare professionals with an interest in oncology. Click here to subscribe.

PART OF THE ONCOLOGY NETWORK... Join Us